We’re excited to announce a major milestone in the world of musculoskeletal care: Groundbreaking research on Apos® marks the first-ever randomized controlled trial (RCT) for chronic low back pain (CLBP) and a direct head-to-head comparison of Apos® against traditional physical therapy (PT).
The study evaluated 162 patients with CLBP, who were randomly assigned to either Apos® or traditional PT and followed for 12 months—providing important long-term evidence.
Key Findings
- Greater Pain Relief: Patients using Apos® had their pain reduced by more than half (56%), compared to 26% with traditional physical therapy (PT).
- Better Daily Function: Patients treated with Apos® were able to move better and enjoy a higher quality of life than those who only did PT.
This means it was easier for them to do everyday activities like walking, climbing stairs, and taking care of themselves. - Faster Walking Speed: People using Apos® could walk at a normal speed again, making it safer for them to cross streets and stay active.
Conclusions
Authors of the research concluded that Apos® has a significant clinical effect in terms of pain reduction and functional improvement. The outcomes associated with Apos® could be attributed to the device’s unique design and ease of usage, which may facilitate better adherence and maintenance of therapeutic effects relative to traditional PT.
Given the persistent challenges surrounding the management of chronic low back pain, including the reliance on pharmacological interventions, the integration of innovative non-surgical approaches such as Apos® presents a potentially valuable addition to existing treatment options.
For more details, the full study can be accessed here.
